References
Lima MM, Padula NA, Santos LC, Oliveira LD, Agapejev S, Padovani C. Critical analysis of the international classification of headache disorders diagnostic criteria (ICHD I-1988) and (ICHD II-2004), for migraine in children and adolescents. Cephalalgia 2005;25: 1042–1047.
Koehler PJ, van de Wiel TW. Aretaeus on migraine and headache. J Hist Neurosci 2001;10: 253–261.
Gladstone JP, Dodick DW. From hemicrania lunaris to hemicrania continua: an overview of the revised International Classification of Headache Disorders. Headache 2004;44: 692–705.
Blau J. Harold G Wolff: the man and his migraine. Cephalalgia 2004;24:215–222.
LI WW, CAI DF. History of taxonomy of headache. Chin J Med His (Chin) 2005;35:230–234.
Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000;55:754–762.
Snow V, Weiss K, Wall EM, Mottur-Pilson C. Pharmacologic management of acute attacks of migraine and prevention of migraine headache. Ann Intern Med 2002;137: 840–849.
Olesen J, Diener HC, Husstedt IW, Goadsby PJ, Hall D, Meier U, et al. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med 2004;350:1104–1110.
Magis D, Ambrosini A, Sandor P, Jacquy J, Laloux P, Schoenen J. A randomized double-blind placebo-controlled trial of thiotic acid in migraine prophylaxis. Headache 2007;47:52–57.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cai, Df. Current progress in the classification and treatment of headache. Chin. J. Integr. Med. 15, 243–247 (2009). https://doi.org/10.1007/s11655-009-0243-4
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11655-009-0243-4